RDNT - These companies set to benefit from sales of Biogen Alzheimer's med Leqembi
2023-09-23 16:00:00 ET
More on GE Healthcare, Siemens, Biogen
- GE Healthcare: Revenue Growth, Margin Expansion And Attractive Valuation
- Siemens Healthineers: The Decline Makes The Upside Better
- Why Did GE HealthCare Excel Beyond The COVID-19 Crisis?
- Biogen: Leqembi Could Boost Prospects Until Acquisition Comes Into Play
- GE HealthCare receives more than $44M grant to build AI-tech
For further details see:
These companies set to benefit from sales of Biogen Alzheimer's med Leqembi